Alvogen

Alvogen snags NRx's bipolar depression drug in $330M deal ahead of late-phase data drop
Fierce Biotech
Wed, 06/7/23 - 09:37 pm
Alvogen
bipolar disorder
NRX-101
clinical trials
AstraZeneca hit with small fine in Korea over plot to stall generic of lucrative cancer med
Fierce Pharma
Fri, 10/14/22 - 10:21 am
South Korea
Alvogen
AstraZeneca
Zoladex
Indivior loses appeal to block generic Suboxone opioid treatments
Reuters
Mon, 07/15/19 - 07:21 pm
Indivior
Dr Reddy's
Alvogen
generics
Suboxone
opioids
U.S. court rejects Alvogen's patent challenge for Celgene's cancer drug
Yahoo/Reuters
Thu, 03/14/19 - 10:18 am
Celgene
Revlimid
patents
Multiple Myeloma
Alvogen
Indivior temporarily stops rival Alvogen's generic launch
Reuters
Fri, 01/25/19 - 11:17 pm
Indivior
Alvogen
generics
opioid addiction
Suboxone
States say Alvogen lawsuit is part of a 'guerilla' war against the death penalty
Fierce Pharma
Sun, 08/12/18 - 01:06 pm
Alvogen
execution drugs
Nevada
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
CP Wire
Thu, 04/5/18 - 11:23 am
Individor
Suboxone Film
patents
Dr Reddy's
Actavis
Par Pharmaceutical
Teva Pharmaceutical
Alvogen
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Fri, 03/23/18 - 09:52 am
Indivior
patents
Suboxone
Alvogen
generics
China Biotech Week In Review: Simcere Pharma Going Private
Seeking Alpha
Sun, 12/22/13 - 12:35 pm
China
Chengdu Kanghong Pharmaceutical Group
MicuRx Pharmaceuticals
Alvogen
Lotus
Chi-Med
Sinopharm
Simcere
GSK
Shanghai Pharmaceutical
Actavis' former CEO is betting on biosimilars
Fierce Pharma
Fri, 12/6/13 - 11:56 am
Actavis
biosimilars
Alvogen
Actavis builder aims to pump up Alvogen
Fierce Pharma
Thu, 07/30/09 - 10:37 am
Actavis
Alvogen